Literature DB >> 2353826

Skin changes in variegate porphyria. Clinical, histopathological, and ultrastructural study.

K Timonen1, K M Niemi, P Mustajoki, R Tenhunen.   

Abstract

The skin of 20 patients with variegate porphyria (VP) was studied using light, fluorescent, and electron microscopy. Twelve patients had skin symptoms and markedly increased fecal protoporphyrin excretion. Their sun-exposed skin was characterized by homogeneous PAS-positive thickening and IgG deposition in the vessel walls. The basic ultrastructural change was thickening of the vascular walls caused by reduplication of the basal lamina and perivascular deposition of amorphous material. Qualitatively similar but less prominent histopathological changes occurred in sun-protected skin in some of the patients. Six patients had no skin symptoms but an increased porphyrin excretion. The light microscopical changes were comparable to those in the patients with skin symptoms, but the ultrastructural changes were less severe. No abnormal histopathological changes occurred in two symptomless patients who had low lymphocyte protoporphyrinogen oxidase activity but normal fecal porphyrin excretion. These results show that the primary site of skin damage in VP is the vessel wall, and that histopathological changes of the skin also occur in porphyric patients who have never had skin symptoms. Factors determining the occurrence of skin symptoms in VP are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2353826     DOI: 10.1007/bf00493468

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  30 in total

1.  Histopathology of porphyria cutanea tarda.

Authors:  M FELDAKER; H MONTGOMERY; L A BRUNSTING
Journal:  J Invest Dermatol       Date:  1955-02       Impact factor: 8.551

2.  Cutaneous changes in the porphyrias. A microscopic study.

Authors:  J H Epstein; D L Tuffanelli; W L Epstein
Journal:  Arch Dermatol       Date:  1973-05

3.  [On the ultrastructure of the skin in erythropoietic protoporphyria].

Authors:  I Anton-Lamprecht; B Meyer
Journal:  Dermatologica       Date:  1970

4.  Variegate porphyria. Twelve years' experience in Finland.

Authors:  P Mustajoki
Journal:  Q J Med       Date:  1980

5.  The clinical and biochemical features of variegate porphyria: an analysis of 300 cases studied at Groote Schuur Hospital, Cape Town.

Authors:  L Eales; R S Day; G H Blekkenhorst
Journal:  Int J Biochem       Date:  1980

6.  Histopathology of the skin in acquired and hereditary porphyria cutanea tarda.

Authors:  R H Cormane; E Szabò; T T Hoo
Journal:  Br J Dermatol       Date:  1971-12       Impact factor: 9.302

7.  Homozygous variegate porphyria. A severe skin disease of infancy.

Authors:  P Mustajoki; R Tenhunen; K M Niemi; Y Nordmann; H Kääriäinen; R Norio
Journal:  Clin Genet       Date:  1987-11       Impact factor: 4.438

8.  Histochemistry of the skin in erythropoietic protoporphyria.

Authors:  E A Ryan
Journal:  Br J Dermatol       Date:  1966-10       Impact factor: 9.302

9.  Ultrastructural abnormalities of the microvasculature and elastic fibers in the skin of juvenile diabetics.

Authors:  I M Braverman; A Keh-Yen
Journal:  J Invest Dermatol       Date:  1984-03       Impact factor: 8.551

10.  Variegate porphyria.

Authors:  P Mustajoki
Journal:  Ann Intern Med       Date:  1978-08       Impact factor: 25.391

View more
  2 in total

Review 1.  [Neurocutaneous porphyrias].

Authors:  J Frank
Journal:  Hautarzt       Date:  2016-03       Impact factor: 0.751

2.  Transient Worsening of Photosensitivity due to Cholelithiasis in a Variegate Porphyria Patient.

Authors:  Shinji Susa; Fumiko Sato-Monma; Kouta Ishii; Yurika Hada; Kaoru Takase; Kyoko Tada; Kiriko Wada; Wataru Kameda; Kentaro Watanabe; Toshihide Oizumi; Tamio Suzuki; Makoto Daimon; Takeo Kato
Journal:  Intern Med       Date:  2016-10-15       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.